M. Nishimura et al., CHARACTERIZATION OF CAMPYLOBACTER-JEJUNI ISOLATES FROM PATIENTS WITH GUILLAIN-BARRE-SYNDROME, Journal of the neurological sciences, 153(1), 1997, pp. 91-99
Campylobacter jejuni is a major pathogen preceding Guillain-Barre synd
rome (GBS), and most C. jejuni isolates from GBS patients belong to Pe
nner serotype 19 (heat-stable; HS-19). We analyzed sixteen independent
clinical isolates from GBS patients, twelve of which belonged to HS-1
9, three to HS-2, and one to HS-4, using PCR-based RFLP analysis of a
flagellin-A (flaA) gene. Two isolates from patients with Miller Fisher
syndrome (MFS), and 27 from patients with uncomplicated enteritis wer
e also examined. All HS-19 isolates, regardless of GBS, showed an iden
tical pattern (Cj-1) by RFLP typing and were distinguishable from thos
e of the other Penner serogroups. In contrast, HS-2 and HS-4 isolates
were divided into several different RFLP groups, suggesting HS-19 stra
ins are genetically distinctive among C. jejuni isolates. A DNA finger
printing method also failed to detect any specific band pattern for GB
S-related C. jejuni isolates. We examined relationships among anti-GM1
antibody titres in the sera of GBS patients, clinical forms of GBS, s
erotype of C. jejuni, and the presence of GM1-like structures in lipop
olysaccharide (LPS) components from C. jejuni isolates by immunoblotti
ng. HS-19 related GBS was significantly associated with elevated anti-
GM1 antibody titers in the sera of the patients, but not associated wi
th any clinical pattern of GBS. No significant correlations were found
between anti-GM1 antibody and the pattern of disease, or between GBS-
related C. jejuni strains and the presence of GM1-like structures. HS-
19 strains seem to be unique among C. jejuni isolates, and HS-19-relat
ed GBS may provide an excellent model for clarification of the pathoge
nesis of GBS. (C) 1997 Elsevier Science B.V.